BARCLAY ALEC (See Remarks) sold 14.4% of their position (12.49K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $23.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/18/2021ACC: 0000899243-21-012548
Officer· See Remarks
Since Jul 2018
-12.49K
Net shares
Net seller
$23.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
12.49K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−12.49K
Price / share
$1.86
Trade value
$23.24K
% of position
14.4%
3/17/2021
86.91K→74.42K
Total
Net shares
−12.49K
Net value
-$23.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2021 | S · Sale | −12.49K | $1.86 | $23.24K | 14.4% | 86.91K | 74.42K |
| Total | −12.49K | -$23.24K | ||||||
Derivative Transactions0
No derivative transactions reported